Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opioids and cardioprotection.

J E Schultz1, G J Gross

  • 1Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, College of Medicine, Cincinnati, OH 45267-0529, USA.

Pharmacology & Therapeutics
|April 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neonatal rectal colonization with Malassezia furfur.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

The neonatal but not the mature heart adapts to acute tachycardia by beneficial modification of the force-frequency relationship.

Pediatric cardiology·2011
Same author

Arrhythmia and sudden death associated with elevated cardiac chloride channel activity.

Journal of cellular and molecular medicine·2010
Same author

Treatment of rats with thyrotropin (TSH) reduces the adrenoceptor sensitivity of adenylate cyclase from cerebral cortex.

Neurochemistry international·2010
Same author

Effects of long-term treatment of rats with antidepressants on adrenergic-receptor sensitivity in cerebral cortex: Structure activity study.

Neurochemistry international·2010
Same author

The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2009
Same journal

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026
Same journal

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026
Same journal

The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

Pharmacology & therapeutics·2026
Same journal

Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

Pharmacology & therapeutics·2026
Same journal

The neurovascular unit under siege: Molecular mechanisms and potential drug target for cerebral edema.

Pharmacology & therapeutics·2026
Same journal

A-type potassium channels in pain signaling: Fundamental mechanisms and pathophysiological roles.

Pharmacology & therapeutics·2026
See all related articles

Opioid receptor activation provides significant cardioprotection, reducing heart attack damage. These findings suggest opioids could treat myocardial infarction pain and limit infarct size, potentially benefiting patients soon.

Area of Science:

  • Cardiovascular Pharmacology
  • Molecular Cardiology
  • Pain Management

Background:

  • Opioid peptides and exogenous opioids like morphine impact cardiovascular function.
  • The cardioprotective effects of opioid receptor activation in reducing infarct size were previously unappreciated.
  • Ischemic preconditioning's protective effects can be blocked by opioid receptor antagonists.

Purpose of the Study:

  • To review the cardioprotective effects of opioid receptor activation.
  • To explore the mechanisms underlying opioid-mediated cardioprotection.
  • To assess the potential clinical application of opioids in myocardial infarction.

Main Methods:

  • Review of studies investigating opioid effects on cardiovascular function and infarct size.

Related Experiment Videos

  • Examination of the role of specific opioid receptor subtypes (e.g., delta1-opioid receptors).
  • Analysis of signaling pathways involved, including Gi/o proteins, protein kinase C, and mitochondrial KATP channels.

    • Main Results:

    • Activation of specific opioid receptors confers potent cardioprotection, reducing infarct size in experimental models.
    • Selective delta(1)-opioid receptor agonists demonstrate significant cardioprotective effects.
    • Opioid-mediated protection involves Gi/o proteins, protein kinase C, and mitochondrial KATP channels, with immediate and delayed effects.

    Conclusions:

    • Opioid receptor agonists show promise for reducing myocardial infarct size.
    • Opioids may offer a dual benefit in myocardial infarction: pain relief and infarct size reduction.
    • Clinical application of existing opioid drugs for cardioprotection may be feasible with minimal further development.